Mental Health Blogs

Just out this morning in AZ’s third quarter financial results is this little whopper:

“Agreement in principle reached with the US Attorney`s Office in Philadelphia to resolve its investigations related to Seroquel sales and marketing practices. This accounts for $520 million of the $538 million provisions taken in the first nine months, $108 million of which taken in third quarter.”

I don’t have any more details on this yet, so stay tuned.

Excepting J&J/Janssen, all the makers of atypicals have agreed to settlements with the feds over illegal marketing.

Go to Source

Related posts:

1. Utah Settles Zyprexa Claims For $24 Million
2. Lilly May Settle Zyprexa Claims With More States
3. AstraZeneca Exec Was Pressed To Lie About Seroquel Weight Gain
4. Lilly Settles Mississippi Zyprexa Claims For $18.5 Million
5. Lilly Settles South Carolina Zyprexa Claims For $45 Million